About ZuriMED Technologies
ZuriMED Technologies is a Healthcare company based in Zurich (Switzerland) founded in 2015, and was acquired by Stryker in August 2026. It operates as a ligament reconstruction devices are developed by ZuriMED Technologies. ZuriMED Technologies has raised $16.7 million across 3 funding rounds from investors including Stryker, Chindex Medical and Innosuisse. ZuriMED Technologies offers products and services including FiberLocker System. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is ZuriMED Technologies AG. Its competitors include Miach Orthopaedics, Rotation Medical, Cayenne Medical, Biorez and OrthoSpace and 4 more; 9 of its 9 listed competitors have raised funding.
Company details
ZuriMED Technologies was founded in 2015 and is based in Zurich, Switzerland, at the Laboratory for Orthopedic Biomechanics at University Hospital Balgrist. Focus is placed on orthopedic biomechanics and biomaterials within the medical device sector. Three devicesBTB Conversion Kit, EndoCLIP, and ZuriACLhave been developed, tested, and patented for ligament reconstruction procedures. Operations center on innovation in orthopedic solutions.
- Headquarters Zurich, Switzerland
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website zurimed.com
- Social LinkedIn X Facebook
- Acquired by Stryker (Aug 2026)
- Legal Name Zurimed Technologies Ag
Products & Services of ZuriMED Technologies
ZuriMED Technologies offers a comprehensive portfolio of products and services, including FiberLocker System.
Device for augmenting rotator cuff repairs in orthopedic surgery.
Funding Insights of ZuriMED Technologies
ZuriMED Technologies has successfully raised a total of $16.7M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $16.56 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.7M
- Total Rounds 3
- Last Round Series A — $16.56M
- First Round $132,924
(Sep 2015)
- Investors Count 4
All 3 funding rounds of ZuriMED Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $2.74M | Grant | – | – | |
| Aug 2023 | $16.56M | Series A | – | Chindex Medical | |
| Sep 2015 | $132,924 | Seed | – | Venture Kick | – |
5 investors in total: 5 institutional.
Investors in ZuriMED Technologies
ZuriMED Technologies has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Stryker, Chindex Medical and Innosuisse.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | yellowstoneholding.ch | - | |
University backed startup accelerator | – | venturekick.ch | Schlieren, Switzerland | |
Innosuisse is engaged in promoting innovation across Swiss organizations. | – | innosuisse.ch | Switzerland | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | stryker.com | Kalamazoo, United States | |
Supplier of chinese medical devices | 2011 | chindexmedical.com | Beijing, China |
Investor details for ZuriMED Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ZuriMED Technologies
14 people are tracked at ZuriMED Technologies (7 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Ronja Senn | Head Of Marketing & Sales | Leadership |
Xiang Li | CEO & Co-founder | Leadership |
Catherine Marcelo | Head Of Finance | Leadership |
Elias Bachmann | CTO | Leadership |
Pol Banzet | Head Of Development | Leadership |
Sebastian Arevalo | Head Of Quality | Leadership |
Sascha Brun | Head Of Active Devices Development | Leadership |
Mariano Perez Chaher | Supplier Quality Engineer | Team |
Ricardo Ribeiro | Quality Engineer | Team |
Ricardo de Sousa Ribeiro | Quality Engineer | Team |
Simon Zollinger | Senior R&d Project Manager | Team |
Cornelius Schlegel | Research And Development Engineer | Team |
Dominic Spothelfer | R&d Engineer | Team |
Janick Eglauf | Market Development Manager | Team |
Complete people profiles for ZuriMED Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ZuriMED Technologies
4 dated milestones of ZuriMED Technologies across 11 years, from founding to its latest funding, stage changes and deals.
- Founded ZuriMED Technologies is founded.
- Funding First funding round of $133K.
- Funding Latest funding round, Series A, of $16.6M.
- Exit Acquired by Stryker.
Competitors of ZuriMED Technologies
ZuriMED Technologies has 9 listed competitors in our database, 9 of them funded. They include Miach Orthopaedics, Rotation Medical, Cayenne Medical, Biorez and OrthoSpace, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| miachortho.com | 2016 | Boston, United States | $72.5M | – | Bio-engineered surgical implants for connective tissue repair are developed. | |
| rotationmedical.com | 2009 | Minneapolis, United States | $54.58M | 34 | A rotator cuff repair system is developed for disease treatment. | |
| cayennemedical.com | 2005 | Phoenix, United States | $46.3M | 54 | Soft tissue reconstruction solutions for knee and shoulder | |
| biorez.com | 2008 | New Haven, United States | $49.11M | – | Bioresorbable scaffolds for ACL soft tissue regeneration are developed. | |
| orthospace.co.il | 2009 | Caesarea, Israel | $23.6M | – | Biodegradable balloon system for rotator cuff tear | |
| nanochon.com | 2016 | Burke, United States | $6M | – | 3D-printed implants are developed for treating joint injuries. | |
| embody-inc.com | 2014 | Norfolk, United States | $41.4M | 25 | Collagen-based regenerative matrices for soft tissue repair are provided. | |
| orthogenrx.com | 2012 | Doylestown, United States | $1.19M | 1,522 | Generic Class III medical devices in orthopedics are developed. | |
| tenexhealth.com | 2009 | Lake, United States | $18.52M | 34 | Minimally invasive therapies are provided for diseased tendon removal. |
Detailed competitors of ZuriMED Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ZuriMED Technologies
The website of ZuriMED Technologies (zurimed.com) receives about 4.3K visits a month.
- Monthly visits4.3K
▲ 74.7% vs previous month
Top companies in Orthopedics
10 companies that operate in the same segment as ZuriMED Technologies (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | 4,125 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zurimed Technologies
Complete news archive for ZuriMED Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZuriMED Technologies
ZuriMED Technologies was founded in 2015.
ZuriMED Technologies is headquartered in Zurich, Switzerland.
ZuriMED Technologies is a funded company, having raised a total of $16.7M across 3 funding rounds to date. The company's 1st funding round was a Seed of $132.92K, raised on Sep 2015.
ZuriMED Technologies was founded in 2015 and is based in Zurich, Switzerland, at the Laboratory for Orthopedic Biomechanics at University Hospital Balgrist. Focus is placed on orthopedic biomechanics and biomaterials within the medical device sector. Three devicesBTB Conversion Kit, EndoCLIP, and ZuriACLhave been developed, tested, and patented for ligament reconstruction procedures. Operations center on innovation in orthopedic solutions.
ZuriMED Technologies's top competitors include Miach Orthopaedics, Nanochon and Tenex Health.
ZuriMED Technologies offers FiberLocker System.
ZuriMED Technologies has 5 investors. Key investors include Stryker, Chindex Medical, Innosuisse, Yellowstone Holding, and Venture Kick.
ZuriMED Technologies operates through Zurimed Technologies Ag.
Yes. ZuriMED Technologies was acquired by Stryker in August 2026.